Compumedics (ASX:CMP) Operating Margin %: 0.14% (As of Dec. 2025)


ASX:CMP Compumedics Ltd ASX:CMP
61 GF Score
Price A$0.26
GF Value A$0.31
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Compumedics Operating Margin %?

Compumedics ASX:CMP +2.00% 61 Operating Margin % is 0.14% as of Dec. 2025. GuruFocus rates ASX:CMP with a GF Score™ of 61/100 and a GF Value™ of A$0.31 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Compumedics ranks worse than 56.25% on this metric.

Operating Margin % is calculated as Operating Income divided by its Revenue. Compumedics's Operating Income for the six months ended in Dec. 2025 was A$0.04 Mil. Compumedics's Revenue for the six months ended in Dec. 2025 was A$30.98 Mil. Therefore, Compumedics's Operating Margin % for the quarter that ended in Dec. 2025 was 0.14%.

Good Sign:

Compumedics Ltd operating margin is expanding. Margin expansion is usually a good sign.

The historical rank and industry rank for Compumedics's Operating Margin % or its related term are showing as below:

ASX:CMP' s Operating Margin % Range Over the Past 10 Years
Min: -10.72   Med: -2.91   Max: 10.94
Current: 0.12


ASX:CMP's Operating Margin % is ranked worse than
56.25% of 816 companies
in the Medical Devices & Instruments industry
Industry Median: 3.465 vs ASX:CMP: 0.12

Compumedics's 5-Year Average Operating Margin % Growth Rate was 3.20% per year.

Compumedics's Operating Income for the six months ended in Dec. 2025 was A$0.04 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.07 Mil.

Warning Sign:

Compumedics Ltd has never been profitable in the past 3 years. It lost money every year.


Compumedics  (ASX:CMP) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Compumedics Operating Margin % Related Terms


Compumedics Operating Margin % Historical Data

* Premium members only.

The historical data trend for Compumedics's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Compumedics Operating Margin % Chart

Compumedics Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.96 -2.85 -10.72 -4.79 -3.07

Compumedics Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.62 -6.12 -6.75 0.10 0.14

ASX:CMP vs ABT, SYK, MDT: Operating Margin % Comparison

For the Medical Devices subindustry, Compumedics's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Compumedics Operating Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Compumedics's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Compumedics's Operating Margin % falls into.


ASX:CMP
61GF Score
Compumedics Ltd ASX:CMP
Operating Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Compumedics Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Compumedics's Operating Margin % for the fiscal year that ended in Jun. 2025 is calculated as

Operating Margin %=Operating Income (A: Jun. 2025 ) / Revenue (A: Jun. 2025 )
=-1.562 / 50.829
=-3.07 %

Compumedics's Operating Margin % for the quarter that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2025 ) / Revenue (Q: Dec. 2025 )
=0.043 / 30.976
=0.14 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of 0.14% mean?
Compumedics (ASX:CMP) has a Operating Margin % of 0.14% as of Dec. 2025. Operating margin is the ratio of total operating income to net sales. View historical data on Compumedics and its competitors. According to the industry distribution chart, Compumedics ranks #459 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 56.2%.
Is Compumedics' Operating Margin % too high?
Compumedics' current Operating Margin % is 0.14%. The Medical Devices & Instruments industry median Operating Margin % is 3.47. Compumedics' value of 0.14% is 96% below this industry median. Based on the distribution chart, Compumedics ranks #459 out of 816 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Compumedics has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Compumedics' Operating Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Compumedics ranks #459 out of 816 companies for Operating Margin %. This places Compumedics in the lower half of its industry. The industry median Operating Margin % is 3.47. Compumedics' value of 0.14% is 96% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Devices & Instruments company?
The median Operating Margin % among Medical Devices & Instruments companies is 3.47, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Compumedics's current Operating Margin % of 0.14% is 96% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Compumedics and its competitors. For the Medical Devices & Instruments industry, the median Operating Margin % is 3.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Compumedics's current Operating Margin % is 0.14%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Compumedics stock overvalued right now?
Based on GuruFocus' analysis, Compumedics (ASX:CMP) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.31, compared to a current price of A$0.26 — trading 17.7% below its estimated fair value. The current Operating Margin % is 0.14% and 96% below the Medical Devices & Instruments industry median of 3.47. Compumedics' overall GF Score™ is 61/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Compumedics (ASX:CMP), the current Operating Margin % is 0.14% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Compumedics (ASX:CMP) Overvalued in 2026?

Based on GuruFocus' analysis, Compumedics stock appears to be undervalued. The current stock price of A$0.26 is trading 17.7% below its estimated GF Value™ of A$0.31. GuruFocus considers Compumedics to be Modestly Undervalued.

Key valuation signals for ASX:CMP:

  • Operating Margin %: 0.14%
  • GF Value™: A$0.31 vs. price of A$0.26 (17.7% below fair value)
  • GF Score™: 61/100 with 4 warning signs
  • Industry Position: 96% below the Medical Devices & Instruments median (#459 of 816)

No single metric tells the full story. See the ASX:CMP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Compumedics Business Description

Address 30-40 Flockhart Street, Abbotsford, Melbourne, VIC, AUS, 3067
Compumedics Ltd is a medical device company. It is engaged in the development, manufacturing, and commercialization of diagnostic technologies for sleep, brain, and ultrasonic blood-flow monitoring applications. The company is organized into geographical operating segments, being the United States of America, Australia and Asia Pacific, and Europe and the Middle East. It derives a majority of its revenue from Australia and the Asia Pacific region.
61GF Score

Get the complete analysis for ASX:CMP

Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.26
Price
A$0.31
GF Value